MEBIS, Jeroen

Email Alert RSS Feed

Profile

Full Name
MEBIS, Jeroen
Email
jeroen.mebis@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 61-80 of 87 (Search time: 0.024 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
612016Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS® laser therapy in breast cancer patientsCensabella, S.; Claes, S.; ROBIJNS, Jolien; BULENS, Paul; MEBIS, JeroenJournal ContributionA1
622016Assessing cancer patients' quality of life and supportive care needs: Translation-revalidation of the CARES in Flemish and exhaustive evaluation of concurrent validitySCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; SCHROOTEN, Ward; BULENS, Paul; Buntinx, Frank; MEBIS, Jeroen; VANDIJCK, Dominique; CLEEMPUT, Irina; HELLINGS, JohanJournal ContributionA1
632016Validation of the flemish CARES, a quality of life and needs assessment tool for cancer careSCHOUTEN, Bojoura; HELLINGS, Johan; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; Buntinx, Frank; MEBIS, Jeroen; VANDIJCK, Dominique; SCHROOTEN, WardJournal ContributionA1
642016Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypNO Stage III-N2 NSCLC after Induction Chemotherapy and ResectionBILLIET, Charlotte; Peeters, Stephanie; Decaluwe, Herbert; Vansteenkiste, Johan; Dooms, Christophe; Deroose, Christophe M.; HENDRIKX, Marc; De Leyn, Paul; BULENS, Paul; KARIM, Rezaul; Le Pechoux, Cecile; MEBIS, Jeroen; De Ruysscher, DirkJournal ContributionA1
652016Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target VolumesBILLIET, Charlotte; De Ruysscher, Dirk; Peeters, Stéphanie; Decaluwé, Herbert; Vansteenkiste, Johan; Dooms, Christophe; Deroose, Christophe M.; De Leyn, Paul; HENDRIKX, Marc; BULENS, Paul; Le Péchoux, Cécile; MEBIS, JeroenJournal ContributionA1
662016Letter regarding "Same strategy for pitfalls of radiotherapy in different anatomical districts"ROBIJNS, Jolien; Censabella, S.; BULENS, Paul; MAES, Annelies; MEBIS, JeroenJournal ContributionA1
672015Thrombo-Embolic Events in Cancer Patients with Impaired Renal FunctionElalamy, I.; Canon, J.L.; Bols, A.; Lybaert, W.; Duck, L.; Jochmans, K.; Bosquée, L.; Peeters, M.; Awada, A.; Clement, P.; Holbrechts, S.; Baurain, J.F.; MEBIS, Jeroen; Nortier, J.Journal ContributionA1
682015Evaluation of the effect of low level laser therapy on oral mucositis in breast cancer patients: a retrospective analysisMEBIS, Jeroen; Censabella, S.; MAES, Annelies; Noé, L.; BULENS, PaulConference MaterialC2
692015Low-level laser therapy as a tool for the management of radiodermatitis: a pilot study in breast cancer patientsROBIJNS, Jolien; CENSABELLA, S.; CLAES, S.; BULENS, Paul; MEBIS, JeroenConference MaterialC2
702015Low level laser therapy for the management of radiation dermatitis: final results of the dermis trial, a pilot study in breast cancer patientsCensabella, S.; ROBIJNS, Jolien; Claes, S.; BULENS, Paul; MEBIS, JeroenProceedings PaperC1
712015Evaluation of the effect of low level laser therapy on oral mucositis in breast cancer patients: A retrospective analysisMEBIS, Jeroen; Censabella, S.; MAES, Annelies; Noé, L.; BULENS, PaulJournal ContributionM
722014LOW LEVEL LASER THERAPY FOR THE MANAGEMENT OF RADIATION DERMATITIS: PRELIMINARY RESULTS OF A PILOT STUDY IN BREAST CANCER PATIENTSCENSABELLA, S.; ROBIJNS, Jolien; CLAES, S.; BULENS, Paul; MEBIS, JeroenJournal ContributionM
732014Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapyBatair, A.; Van Fraeyenhoven, F.; Vandebroek, A.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
742013‘Screening cancer patients distress and care needs: translation and validation of the Cancer Rehabilitation Evaluation System (CARES) for the Flemish population in Belgium.’SCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; MEBIS, Jeroen; Vandenborre, Katherine; HELLINGS, JohanConference MaterialC2
752013Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case reportVan Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen; MEBIS, JeroenJournal ContributionA2
762013Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancerBaitar, A.; van Fraeyenhove, F.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
772012The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years laterVanderhaegen, J.; Paridaens, R.; Piccart, M.; Lalami, Y.; Machiels, J.P.; Jerusalem, G.; Borms, M.; Goemine, J.; MEBIS, Jeroen; Dirix, L.; Lintermans, A.; Brouckaert, O.; Neven, P.Conference MaterialC2
782012Will ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events?MEBIS, JeroenConference MaterialC2
792012Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment).Wolter, Pascal; Hendrickx, Tine; Renard, Vincent; MEBIS, Jeroen; Debruyne, Philip R.; Wynendaele, Wim; Schallier, Denis C. C.; Vermeij, Joanna; Nielander, Aldrik; Machiels, Jean-Pascal H.; Rottey, Sylvie; Delande, Stephanie; Goeminne, Jean-Charles; Schoffski, Patrick; De Coster, Sandra; Lacour, Valerie; Foulon, VeerleJournal ContributionM
802012Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST TrialLlombart, Antonio; Frassoldati, Antonio; Paija, Outi; Sleeboom, Harm Peter; Jerusalem, Guy; MEBIS, Jeroen; Deleu, Ines; Miller, Joel; Schenk, Nora; Neven, PatrickJournal ContributionA1
show all